Dr. Clay Siegall is one of the most educated and accomplished doctors in the US today. He has used his extensive educational-base to fight the damaging effects of cancer. Siegall is the CEO of a biotech-oncology organization that’s headquartered in Bothell, Washington. This organization is known as Seattle Genetics, and it’s seated at the forefront of cancer research. Seattle Genetics develops and commercializes targeted-cancer therapies. Siegall has implemented a ton of research into this program. On top of that, he has incorporated plenty of scientific innovation and drug development right into Seattle Genetics’ system.
Clay Siegall is basically a scientist by training. The guy has a bachelor’s degree in Zoology as well as a Ph.D. in Genetics. Of course, he attained these certifications from the University of Maryland and from George Washington University. When it comes to be being acclaimed, Siegall is well ahead of his classmates. He has won various awards throughout the years, including the University of Maryland Alumnus of the Year for Computer, Math & Natural Science in 2013. In 2012, he won the Pacific Northwest Ernst & Young Entrepreneur of the Year Award. Siegall has also written upward of 65 medical-related publications. “I’ve been in this field for 30 years, and I’m very excited to see where this field is going,” said Siegall. This medical professional got into this profession because of his father. Cancer certainly hit home back when he was only 19 years old, and he has been doing a fantastic job of saving lives ever since.
Seattle Genetics is one of the largest employers in the Puget Sound area. There are close to 1,000 people who earn a good living by working for SG. A few years ago, former-Vice President Joe Biden stopped by for a quick visit. As of 2018, Seattle Genetics is now worth an estimated $10 billion thanks to the efforts of Dr. Clay Siegall.